Skip to main content

Testicular Cancer

  • Chapter
  • First Online:
Urology at a Glance

Abstract

Though testicular cancer (TC) is the most common malignancy in 15–35-year-old men [1], it accounts for only 1–2 % of all neoplasms in men [2]. Worldwide, the incidence of TC has doubled in 40 years [3]. Risk factors for TC include cryptorchidism, a personal or family history of TC, and intratubular germ cell neoplasia. Over 95 % of testicular cancers are germ cell tumors, including seminomas and nonseminomatous tumors; non-germ cell tumors, including Leydig and Sertoli cell tumors, account for <5 % of all testicular cancers [4]. Men generally present with localized disease (69 %). Five-year relative survival, inclusive of all stages, is 95.3 % [5].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. Masterson TA, Beck SDW. Testicular cancer: clinical signs and symptoms. In: Scardino PT, Linehan WM, Zelefsky MJ, Vogelzang NJ, editors. Comprehensive textbook of genitourinary oncology. Philadelphia: Wolters Kluwer; 2011. p. 505–8.

    Google Scholar 

  2. Huyghe E, Matsuda T, Thonneau P. Increasing incidence of testicular cancer worldwide: a review. J Urol. 2003;170(1):5–11.

    Article  PubMed  Google Scholar 

  3. National Comprehensive Cancer Network. Testicular cancer (Version 1.2013). http://www.nccn.org/professionals/physician_gls/pdf/testicular.pdf. Accessed 15 Sept 2013.

  4. Stephenson AJ, Gilligan TD. Neoplasms of the testis. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 10th ed. Philadelphia: Elsevier; 2011. p. 837–70.

    Google Scholar 

  5. National Cancer Institute SEER Stat Fact Sheets: Testis. http://seer.cancer.gov/statfacts/html/testis.html. Accessed 15 Sept 2013.

  6. Moul JW. Timely diagnosis of testicular cancer. Urol Clin North Am. 2007;34(2):109–17.

    Article  PubMed  Google Scholar 

  7. Kaufman MR, Chang SS. Short and long-term complications of therapy for testicular cancer. Urol Clin North Am. 2007;34(2):259–68.

    Article  PubMed  Google Scholar 

  8. Tarin TV, Sonn G, Shinghal R. Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computed tomography. J Urol. 2009;181(2):627–33.

    Article  PubMed  Google Scholar 

  9. Reuter VE. Anatomy and pathology of testis cancer. In: Scardino PT, Linehan WM, Zelefsky MJ, Vogelzang NJ, editors. Comprehensive textbook of genitourinary oncology. 4th ed. Philadelphia: Wolters Kluwer; 2011. p. 531–41.

    Google Scholar 

  10. Carver BS, Feldman DR. Staging of testicular cancer. In: Scardino PT, Linehan WM, Zelefsky MJ, Vogelzang NJ, editors. Comprehensive textbook of genitourinary oncology. 4th ed. Philadelphia: Wolters Kluwer; 2011. p. 544–7.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2014 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

McGinley, K.F., Rampersaud, E.N. (2014). Testicular Cancer. In: Merseburger, A., Kuczyk, M., Moul, J. (eds) Urology at a Glance. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-54859-8_57

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-54859-8_57

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-54858-1

  • Online ISBN: 978-3-642-54859-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics